ERNEST THOMPSON: Open Payments
NPI 1841212610 · BAKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,206 in 93 payments from 24 companies in 2025. Trend: 2023 $1,660 · 2024 $1,219 · 2025 $2,206
Food & beverage: $2,206
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $389 |
| Abbott Laboratories | 6 | $204 |
| AstraZeneca Pharmaceuticals LP | 5 | $201 |
| E.R. Squibb & Sons, L.L.C. | 9 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $152 |
| Otsuka America Pharmaceutical, Inc. | 2 | $145 |
| Ardelyx, Inc. | 8 | $144 |
| ABBVIE INC. | 11 | $137 |
| Axsome Therapeutics, Inc. | 6 | $125 |
| Vanda Pharmaceuticals Inc. | 3 | $103 |
Products named: CAPLYTA, FREESTYLE LIBRE 3, COBENFY, AIRSUPRA, REXULTI, Kerendia, IBSRELA, Auvelity.
Industry payments across LA — which companies pay providers there.
